Michael Lahn
Company: iOnctura SA
Job title: Chief Medical Officer
Seminars:
Leveraging the Lessons from Past Drug Development Experiences 2:10 pm
Exploring the degree of inhibition to achieve clinically meaningful outcomes Using preclinical data to predict target modulation and efficacy in patients Navigating alternative pathways to target TGF-β signalling, including blocking the enzyme autotaxinRead more
day: Day One